{
  "articles": [
    {
      "path": "about.html",
      "title": "About this site",
      "description": "Some additional details about the website",
      "author": [],
      "contents": "\r\nBorn frequentist, Francois Mercier gradually developed an interest for the Bayesian formalism and use it now as main M&S framework.\r\nHe frequently collaborates with statistical engineers, and researchers who study Bayesian causal inference and machine learning.\r\nHe has contributed to\r\n* 50+ clinical development programs (Phase 1 to Phase 3),\r\n* 4 NDAs (Fingolimod, Siponimod, Ocrelizumab, and Entrectinib.\r\n* 50+ scientific articles in statistics and clinical journals,\r\n* 100+ scientific posters,\r\n* 40+ oral communications in major conferences.\r\n\r\n\r\n\r\n",
      "last_modified": "2023-08-19T18:04:52+02:00"
    },
    {
      "path": "index.html",
      "title": "Francois Mercier",
      "author": [],
      "contents": "\r\n\r\n          \r\n          \r\n          mercifr1 pages\r\n          \r\n          \r\n          Home\r\n          About\r\n          ☰\r\n          \r\n          \r\n      \r\n        \r\n          \r\n            \r\n              \r\n            \r\n              Francois Mercier\r\n            \r\n            \r\n              \r\n                \r\n                    \r\n                      \r\n                        LinkedIn\r\n                      \r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      \r\n                        GitHub\r\n                      \r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      \r\n                        Email\r\n                      \r\n                    \r\n                  \r\n                                  \r\n            \r\n          \r\n        \r\n        \r\n        \r\n          \r\n            \r\n            Bio\r\n            Francois Mercier does modeling and simulation (M&S)\r\n            at Roche-Genentech to support decision-making in clinical\r\n            drug development. His research focuses on dose-finding, and\r\n            composite data models such as joint models, in oncology and\r\n            neuroscience. Born frequentist, he gradually developed an\r\n            interest for the Bayesian formalism and use it now as main\r\n            M&S framework. He frequently collaborates with\r\n            statistical engineers, and researchers who study Bayesian\r\n            causal inference and machine learning. He has contributed to\r\n            50+ clinical development programs in his career, among which\r\n            3 delivered NDAs: Fingolimod, Siponimod, Ocrelizumab, and\r\n            Entrectinib. He has published 50+ scientific articles in\r\n            statistics and clinical journals, presented 100+ scientific\r\n            posters, and delivered 40+ oral communications in major\r\n            conferences.\r\n            \r\n            \r\n            Education\r\n            Massachusetts Institute of Technology |\r\n            Cambridge, MA\r\n            Ph.D. in Computer Science | September 2009 - May 2014\r\n            The University of California, Berkeley |\r\n            Berkeley, CA\r\n            B.S. in Computer Science | September 2005 - May 2009\r\n            \r\n            \r\n            Experience\r\n            Google Brain | Principal Investigator |\r\n            January 2018 - Present\r\n            Netflix | Research Scientist | June 2014\r\n            - December 2017\r\n            \r\n          \r\n        \r\n      \r\n    \r\n\r\n    \r\n      \r\n        \r\n          \r\n            \r\n              \r\n            \r\n              Francois Mercier\r\n            \r\n            \r\n              \r\n                \r\n                                    \r\n                    \r\n                      LinkedIn\r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      GitHub\r\n                    \r\n                  \r\n                                    \r\n                    \r\n                      Email\r\n                    \r\n                  \r\n                                  \r\n              \r\n            \r\n            \r\n              \r\n              Bio\r\n              Francois Mercier does modeling and simulation (M&S)\r\n              at Roche-Genentech to support decision-making in clinical\r\n              drug development. His research focuses on dose-finding,\r\n              and composite data models such as joint models, in\r\n              oncology and neuroscience. Born frequentist, he gradually\r\n              developed an interest for the Bayesian formalism and use\r\n              it now as main M&S framework. He frequently\r\n              collaborates with statistical engineers, and researchers\r\n              who study Bayesian causal inference and machine learning.\r\n              He has contributed to 50+ clinical development programs in\r\n              his career, among which 3 delivered NDAs: Fingolimod,\r\n              Siponimod, Ocrelizumab, and Entrectinib. He has published\r\n              50+ scientific articles in statistics and clinical\r\n              journals, presented 100+ scientific posters, and delivered\r\n              40+ oral communications in major conferences.\r\n              \r\n              \r\n              Education\r\n              Massachusetts Institute of Technology\r\n              | Cambridge, MA\r\n              Ph.D. in Computer Science | September 2009 - May\r\n              2014\r\n              The University of California, Berkeley\r\n              | Berkeley, CA\r\n              B.S. in Computer Science | September 2005 - May\r\n              2009\r\n              \r\n              \r\n              Experience\r\n              Google Brain | Principal Investigator\r\n              | January 2018 - Present\r\n              Netflix | Research Scientist | June\r\n              2014 - December 2017\r\n              \r\n            \r\n        \r\n      \r\n    \r\n\r\n    \r\n    \r\n    ",
      "last_modified": "2023-08-19T18:01:05+02:00"
    }
  ],
  "collections": []
}
